SHINSHU UNIVERSITY

🇯🇵Japan

Country: 🇯🇵Japan

Ownership: Private

Established: 1949-05-01

Employees: 501

Market Cap: -

Website: http://www.shinshu-u.ac.jp

Clinical Trials

Effect of Tofogliflozin on UACR Compared to Metformin Hydrochloride in Diabetic Kidney Disease (TRUTH-DKD)

Phase 2

Recruiting

Conditions: T2DM (Type 2 Diabetes Mellitus)
SGLT2-Inhibitors
Metformin

Interventions: Drug: Metformin
Drug: Tofogliflozin

First Posted Date: 2022-07-22

Last Posted Date: 2022-07-22

Lead Sponsor: Shinshu University

Target Recruit Count: 120

Registration Number: NCT05469659

Locations: 🇯🇵
Shinshu University, Matsumoto, Nagano, Japan

Usefulness of Non TNF Usage in RA Patients

Phase 2

Recruiting

Conditions: Rheumatoid Arthritis

First Posted Date: 2018-12-21

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 90

Registration Number: NCT03784261

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Examination of Efficacy and Safety of Baricitinib in RA Patients

Phase 2

Recruiting

Conditions: Rheumatoid Arthritis

Interventions: Drug: "Biologics"
Drug: "Baricitinib", "olumiant®"
Drug: Tofacitinib 5 MG [Xeljanz]

First Posted Date: 2018-11-28

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 90

Registration Number: NCT03755466

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Examination of Efficacy and Safety of Other Anti-Resorption Drugs After 2-year-Denosumab Therapy in Japanese Osteoporosis Patients

Phase 2

Recruiting

Conditions: Osteoporosis

Interventions: Drug: SERM "Viviant®Tablet 20mg" and ELD "Edirol®Tablet 0.75ug"
Drug: Bisphosphonates and ELD "Edirol®Tablet 0.75ug"
Drug: ELD "Edirol®Tablet 0.75ug"

First Posted Date: 2018-11-27

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 90

Registration Number: NCT03755193

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Examination How the Administration Period of Teriparatide Affects Bone Metabolism and Bone Mineral Density Prior to Denosumab Therapy

Phase 2

Recruiting

Conditions: Osteoporosis

Interventions: Drug: "Teriparatide", "Forteo® or Teribon"

First Posted Date: 2018-10-10

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 90

Registration Number: NCT03702140

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Efficacy of Proton Pump Inhibitors in Gastrointestinal Erosions and/or Ulcers

Phase 2

Recruiting

Conditions: Gastrointestinal Erosions and/or Ulcers

Interventions: Drug: Oral Bonoprazan
Drug: Oral Esomeprazol

First Posted Date: 2017-10-20

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 124

Registration Number: NCT03315676

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Efficacy of Oral Ibandronate in Osteoporosis

Phase 2

Recruiting

Conditions: Osteoporosis

Interventions: Drug: Ibandronate
Drug: Oral Ibandronate and Vitamin D

First Posted Date: 2017-06-14

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 100

Registration Number: NCT03186131

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Efficacy of Zoledronic Acid in Osteoporosis

Phase 2

Recruiting

Conditions: Osteoporosis

Interventions: Drug: "Zoledronic acid", "Reclast®"
Drug: "Zoledronic acid", "Reclast®" and "active vitamin D", "alfacalcidol®"

First Posted Date: 2017-06-12

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 100

Registration Number: NCT03183557

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

Non-weight Bearing in Hip Joint With Accompanying Joint Pain Might Not Progress Radiographic OA

Not Applicable

Recruiting

Conditions: Hip OA

Interventions: Procedure: To MRI-detecting bone signal changes in radiographic hip OA

First Posted Date: 2014-12-31

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 100

Registration Number: NCT02329093

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Nagano, Japan

To Examine Whether or Not the Primary Causes of OA or RA Might be Bone Alterations

Recruiting

Conditions: Progression of Rheumatoid Arthritis
Osteoarthritis of Multiple Joints

Interventions: Procedure: The examinations for bones in joints of OA and RA patients

First Posted Date: 2014-12-30

Last Posted Date: 2021-09-21

Lead Sponsor: Shinshu University

Target Recruit Count: 200

Registration Number: NCT02327650

Locations: 🇯🇵
Yukio Nakamura, Matsumoto, Japan

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy